Radcliffe Capital Management’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-150,000
| Closed | -$1.51M | – | 832 |
|
|
2022
Q4 | $1.51M | Hold |
150,000
| – | – | 0.05% | 565 |
|
|
2022
Q3 | $1.49M | Hold |
150,000
| – | – | 0.04% | 779 |
|
|
2022
Q2 | $1.47M | Hold |
150,000
| – | – | 0.03% | 823 |
|
|
2022
Q1 | $1.47M | Hold |
150,000
| – | – | 0.03% | 804 |
|
|
2021
Q4 | $1.46M | Hold |
150,000
| – | – | 0.04% | 699 |
|
|
2021
Q3 | $1.45M | Hold |
150,000
| – | – | 0.04% | 588 |
|
|
2021
Q2 | $1.45M | Buy |
+150,000
| New | +$1.45M | 0.05% | 614 |
|